POLLS     NHL STATS     SEARCH

TRENDING NOW


BRUINS LATEST  |  NHL  |  NEWS

Forbes' NHL franchise valuation list for 2023 sees a new team taking the lead

PUBLICATION
Christopher Faucher
December 18, 2023  (10:11)
SHARE THIS STORY

Photo credit: nhl.com

As the year approaches its final weeks, Forbes has unveiled its 2023 assessment of the 32 National Hockey League franchises, revealing a different team at the forefront.

Traditionally leading Forbes' rankings, the New York Rangers have now been surpassed in 2023 by the Toronto Maple Leafs, holding the top position with a current valuation of $2.8 billion USD, signifying a remarkable 40% surge from the previous year.

"The Toronto Maple Leafs are the most valuable team in the National Hockey League for the first time since 2014. Even though they have not won the Stanley Cup since 1967, Forbes values the Maple Leafs at $2.8 billion, $150 million more than the New York Rangers ($2.65 billion), who held the top spot for eight straight years. The Montreal Canadiens are the NHL's third-most-valuable team, worth $2.3 billion."


The New York Rangers slid to second place, despite a 20% surge in value from 2022, now positioned at $2.65 billion USD. Following them in the top-five are the Montreal Canadiens ($2.3 billion), Los Angeles Kings ($2 billion), and Boston Bruins ($1.9 billion).

Also featured in Forbes' top-ten list are the Chicago Blackhawks ($1.87 billion), Edmonton Oilers ($1.85 billion), Philadelphia Flyers ($1.65 billion), Washington Capitals ($1.6 billion), and New York Islanders ($1.55 billion).

According to Forbes, the Arizona Coyotes, still seeking a permanent location in the state, hold the lowest valuation among National Hockey League teams, currently resting at $500 million USD.

Source: bladeofsteel

POLL
18 DECEMBRE   |   97 ANSWERS
Forbes' NHL franchise valuation list for 2023 sees a new team taking the lead

Are you surprised that the Bruins are 5th?

Yes4546.4 %
No5253.6 %
List of polls
Latest 10 stories
pub
BRUINSLATEST.COM
COPYRIGHT @2024 - ALL RIGHTS RESERVED.
TERMS  -  POLICIES  -  CONSENT